BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38930020)

  • 1. Serum Calcification Propensity T50 Is Associated with Soluble Thrombomodulin in Patients on Hemodialysis.
    Tadokoro T; Kato A; Ohmori H; Matsumoto T; Kuro-O M; Kobayashi T; Ohdan H
    J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38930020
    [No Abstract]   [Full Text] [Related]  

  • 2. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
    Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
    Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum calcification propensity and its association with biochemical parameters and bone mineral density in hemodialysis patients.
    Kim H; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Jung JY
    Kidney Res Clin Pract; 2023 Mar; 42(2):262-271. PubMed ID: 36328988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.
    Dekker M; Pasch A; van der Sande F; Konings C; Bachtler M; Dionisi M; Meier M; Kooman J; Canaud B
    PLoS One; 2016; 11(4):e0151508. PubMed ID: 27064679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review.
    Pluquet M; Kamel S; Choukroun G; Liabeuf S; Laville SM
    Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial.
    Bressendorff I; Hansen D; Schou M; Pasch A; Brandi L
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1373-1380. PubMed ID: 30131425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.
    Pasch A; Block GA; Bachtler M; Smith ER; Jahnen-Dechent W; Arampatzis S; Chertow GM; Parfrey P; Ma X; Floege J
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):315-322. PubMed ID: 27940458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study.
    Dörr K; Hödlmoser S; Kammer M; Reindl-Schwaighofer R; Lorenz M; Reiskopf B; Jagoditsch R; Marculescu R; Oberbauer R
    Front Med (Lausanne); 2022; 9():948177. PubMed ID: 35872799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Serum Zinc and Calcification Propensity (T
    Nakatani S; Mori K; Sonoda M; Nishide K; Uedono H; Tsuda A; Emoto M; Shoji T
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32916995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study.
    Lorenz G; Mayer CC; Bachmann Q; Stryeck S; Braunisch MC; Haller B; Carbajo-Lozoya J; Schmidt A; Witthauer S; Abuzahu J; Kemmner S; Angermann S; Koneru N; Wassertheurer S; Bieber R; Heemann U; Madl T; Pasch A; Schmaderer C
    Nephrol Dial Transplant; 2018 Nov; 33(11):2043-2051. PubMed ID: 29860419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Bundy JD; Cai X; Scialla JJ; Dobre MA; Chen J; Hsu CY; Leonard MB; Go AS; Rao PS; Lash JP; Townsend RR; Feldman HI; de Boer IH; Block GA; Wolf M; Smith ER; Pasch A; Isakova T;
    Am J Kidney Dis; 2019 Jun; 73(6):806-814. PubMed ID: 30935773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of a serum calcification propensity test for the prediction of all-cause mortality among hemodialysis patients.
    Zawada AM; Wolf M; Rincon Bello A; Ramos-Sanchez R; Hurtado Munoz S; Ribera Tello L; Mora-Macia J; Fernández-Robres MA; Soler-Garcia J; Aguilera Jover J; Moreso F; Stuard S; Stauss-Grabo M; Winter A; Canaud B
    BMC Nephrol; 2023 Feb; 24(1):35. PubMed ID: 36792998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Calcification Propensity Is Increased in Myocardial Infarction and Hints at a Pathophysiological Role Independent of Classical Cardiovascular Risk Factors.
    Mencke R; Al Ali L; de Koning MLY; Pasch A; Minnion M; Feelisch M; van Veldhuisen DJ; van der Horst ICC; Gansevoort RT; Bakker SJL; de Borst MH; van Goor H; van der Harst P; Lipsic E; Hillebrands JL
    Arterioscler Thromb Vasc Biol; 2024 Jun; ():. PubMed ID: 38899469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Calcification Propensity and Clinical Events in CKD.
    Bundy JD; Cai X; Mehta RC; Scialla JJ; de Boer IH; Hsu CY; Go AS; Dobre MA; Chen J; Rao PS; Leonard MB; Lash JP; Block GA; Townsend RR; Feldman HI; Smith ER; Pasch A; Isakova T;
    Clin J Am Soc Nephrol; 2019 Nov; 14(11):1562-1571. PubMed ID: 31658949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Calcification Propensity and the Risk of Cardiovascular and All-Cause Mortality in the General Population: The PREVEND Study.
    Eelderink C; Te Velde-Keyzer CA; Frenay AS; Vermeulen EA; Bachtler M; Aghagolzadeh P; van Dijk PR; Gansevoort RT; Vervloet MG; Hillebrands JL; Bakker SJL; van Goor H; Pasch A; de Borst MH;
    Arterioscler Thromb Vasc Biol; 2020 Aug; 40(8):1942-1951. PubMed ID: 32493170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism.
    Kantauskaite M; Bolten K; Boschheidgen M; Schmidt C; Kolb T; Eckardt KU; Pasch A; Schimmöller L; Rump LC; Voelkl J; Stegbauer J
    Front Cardiovasc Med; 2022; 9():771096. PubMed ID: 35141300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification Propensity.
    Halfon M; Zhang L; Ehirchiou D; Pandian VD; Dahdal S; Huynh-Do U; Pasch A; Ribi C; Busso N
    Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of six-month oral vitamin K supplementation on calcification propensity time in individuals with type 2 diabetes mellitus: A post hoc analysis of a randomized, double-blind, placebo-controlled trial.
    Meer R; Romero Prats ML; Vervloet MG; van der Schouw YT; de Jong PA; Beulens JWJ
    Atherosclerosis; 2024 Jul; 394():117307. PubMed ID: 37852868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Calcification Propensity T50 Associates with Disease Severity in Patients with Pseudoxanthoma Elasticum.
    Nollet L; Van Gils M; Fischer S; Campens L; Karthik S; Pasch A; De Zaeytijd J; Leroy BP; Devos D; De Backer T; Coucke PJ; Vanakker OM
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening calcification propensity precedes all-cause and cardiovascular mortality in haemodialyzed patients.
    Lorenz G; Steubl D; Kemmner S; Pasch A; Koch-Sembdner W; Pham D; Haller B; Bachmann Q; Mayer CC; Wassertheurer S; Angermann S; Lech M; Moog P; Bauer A; Heemann U; Schmaderer C
    Sci Rep; 2017 Oct; 7(1):13368. PubMed ID: 29042624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.